Next Article in Journal
Exosome-Based Carrier for RNA Delivery: Progress and Challenges
Previous Article in Journal
Lipopolyplex-Mediated Co-Delivery of Doxorubicin and FAK siRNA to Enhance Therapeutic Efficiency of Treating Colorectal Cancer
Previous Article in Special Issue
Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(2), 597; https://doi.org/10.3390/pharmaceutics15020597
Action Date Notes Link
article xml file uploaded 10 February 2023 09:22 CET Original file -
article xml uploaded. 10 February 2023 09:22 CET Update https://www.mdpi.com/1999-4923/15/2/597/xml
article pdf uploaded. 10 February 2023 09:22 CET Version of Record https://www.mdpi.com/1999-4923/15/2/597/pdf
article html file updated 10 February 2023 09:23 CET Original file -
article html file updated 1 March 2023 13:42 CET Update https://www.mdpi.com/1999-4923/15/2/597/html
Back to TopTop